Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display

Biological Chemistry

Volumn 389, Issue 8, 2008, Pages 1097-1105

  Sharma, Navneet ^a   Oikonomopoulou, Katerina ^b,c   Ito, Kenichi ^a   Renaux, Bernard ^a   Diamandis, Eleftherios P ^b,c   Hollenberg, Morley D ^a   Rancourt, Derrick E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Enzyme specificity; Human kallikrein related peptidase; Implantation serine proteinase; Phage display; T7 bacteriophage

Indexed keywords

ARGININE; CHYMOTRYPSIN; HEXAPEPTIDE; KALLIKREIN 6; LYSINE; PEPTIDE LIBRARY; RECOMBINANT ENZYME; SERINE PROTEINASE; TRYPTASE; TRYPTOPHAN;

AMINO ACID SEQUENCE; BACTERIOPHAGE T7; BIOPANNING; CONFERENCE PAPER; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME SPECIFICITY; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MOTIF;

AMINO ACID SEQUENCE; ANIMALS; BACTERIOPHAGE T7; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICE; PEPTIDE LIBRARY; SERINE ENDOPEPTIDASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; TITRIMETRY;

EID: 50849107686     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.118     Document Type: Conference Paper

References (32)

1. Angelo, P.F., Lima, A.R., Alves, F.M., Blaber, S.I., Scarisbrick, I.A., Blaber, M., Juliano, L., and Juliano, M.A. (2006). Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J. Biol. Chem. 281, 3116-3126.
2. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
3. Borgoño, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
4. Borgoño, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2, 257-280.
5. Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J., and Deperthes, D. (2002). Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur. J. Biochem. 269, 2747-2754.
6. Cwirla, S.E., Peters, E.A., Barrett, R.W., and Dower, W.J. (1990). Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87, 6378-6382.
7. Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C.S., Choe, Y., Bode, W., and Goettig, P. (2006). Specificity profiling of seven human kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678-25688.
8. Deperthes, D. (2002). Phage display substrate: a blind method for determining protease specificity. Biol. Chem. 383, 1107-1112.
9. Diamandis, E.P., Scorilas, A., Fracchioli, S., Van Gramberen, M., De Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G.M., Stenman, U.H., et al. (2003). Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 21, 1035-1043.
10. Felber, L.M., Borgoño, C.A., Cloutier, S.M., Kündig, C., Kishi, T., Ribeiro Chagas, J., Jichlinski, P., Gygi, C.M., Leisinger, H.J., Diamandis, E.P., et al. (2005). Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biol. Chem. 386, 291-298.
11. Ghosh, M.C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and Diamandis, E.P. (2004). Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193-199.
12. Hoffman, B.R., Katsaros, D., Scorilas, A., Diamandis, P., Fracchioli, S., Rigault de la Longrais, I.A., Colgan, T., Puopolo, M., Giardina, G., Massobrio M., et al. (2002). Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br. J. Cancer 87, 763-771.
13. Huang, Z.P., Yu, H., Yang, G.M., Shen, W.X., Wang, J., and Shen, Q.X. (2004). Uterine expression of implantation serine proteinase 2 during the implantation period and in vivo inhibitory effect of its antibody on embryo implantation in mice. Reprod. Fertil. Dev. 16, 379-384.
14. Karlson, U., Pejler, G., Froman, G., and Hellman, L. (2002). Rat mast cell proteinase 4 is a β-chymase with unusually stringent substrate recognition profile. J. Biol. Chem. 277, 18579-18585.
15. Karlson, U., Pejler, G., Tomasini-Johansson, B., and Hellman, L. (2003). Extended substrate specificity of rat mast cell proteinase 5, a rodent α-chymase with elastase-like primary specificity. J. Biol. Chem. 278, 39625-39631.
16. McCafferty, J., Griffiths, A.D., Winter, G., and Chriswell, D.J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552-554.
17. Magklara, A., Mellati, A.A., Wasney, G.A., Little, S.P., Sotiropoulou, G., Becker, G.W., and Diamandis, E.P. (2003). Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 307, 948-955.
18. Matthews, D.J. and Wells, J.A. (1993). Substrate phage: selection of proteinase substrates by monovalent phage display. Science 260, 1113-1117.
19. O'Sullivan, C.M., Rancourt, S.L., Liu, S.Y., and Rancourt, D.E. (2001). A novel murine tryptase involved in blastocyst hatching and outgrowth. Reproduction 122, 61-71.
20. O'Sullivan, C.M., Liu, S.Y., Karpinka, J.B., and Rancourt, D.E. (2002). Embryonic hatching enzyme trypsin/ISP1 is expressed with ISP2 in endometrial glands during implantation. Mol. Reprod. Dev. 62, 328-334.
21. Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G.S., Bunnett, N.W., et al. (2006a). Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095-32112.
22. Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Vergnolle, N., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Diamandis, E.P., and Hollenberg, M.D. (2006b). Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol. Chem. 387, 817-824.
23. Oikonomopoulou, K., Hansen, K.K., Baruch, A., Hollenberg, M.D., and Diamandis, E.P. (2008). Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids. Biol. Chem. 389, 747-756.
24. Pei, D. and Weiss, S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
25. Puente, X.S., Sanchez, L.M., Overall, C.M., and Lopez-Otin, C. (2003). Human and mouse proteinases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558.
26. Rawlings, N.D., Morton, F.R., and Barrett, A.J. (2006). MEROPS: the peptidase database. Nucleic Acids Res. 34, D270-272.
27. Santin, A.D., Diamandis, E.P., Bellone, S., Soosaipillai, A., Cane, S., Palmieri, M., Burnett, A., Roman, J.J., and Pecorelli, S. (2005). Human kallikrein 6: a new potential serum biomarker for uterine serous pappillary cancer. Clin. Cancer Res. 11 3320-3325.
28. Sharma, N., Liu, S., Tang, L., Irwin, J., Meng, G., and Rancourt, D.E. (2006). Implantation serine proteinases heterodimerize and are critical in hatching and implantation. BMC Dev. Biol. 6, 61.
29. Shaw, J.L. and Diamandis, E P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
30. Smith, G.P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1317.
31. Sternlicht, M.D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
32. Yousef, G.M., Borgoño, C.A., White, N.M., Robb, J.D., Michael, I.P., Oikonomopoulou, K., Khan, S., and Diamandis, E.P. (2004). In silico analysis of the human kallikrein gene 6. Tumour Biol. 25, 282-289.